Seroprevalence of anti-sars-cov-2 specific antibodies in vaccinated and vaccine naïve adult nigerians

HIGHLIGHTS

• who: Abdulfattah Adekunle Onifade et al. from the Department of Immunology, College of Medicine, University of Ibadan, Ibadan, Nigeria, Biorepository have published the article: Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine nau00efve adult Nigerians, in the Journal: PLOS ONE of December/26,/2022
• what: Interestingly, results from the study showed that participants who had Astrazeneca vaccine had similar antibody response with those that took Moderna vaccine.
• how: In the study a dissimilar pattern was observed as the proportion of participants with SARS-CoV-2 specific IgG was insignificantly . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.